(CAMT) Camtek - Overview
Sector: Technology | Industry: Semiconductor Equipment & Materials | Exchange: NASDAQ (USA) | Market Cap: 7.052m USD | Total Return: 153.5% in 12m
Avg Turnover: 84.3M
EPS Trend: 97.6%
Qual. Beats: 0
Rev. Trend: 98.0%
Qual. Beats: 1
Warnings
P/E ratio 156.0
Below Avwap Earnings
Tailwinds
No distinct edge detected
Camtek Ltd. (CAMT) designs and manufactures high-end inspection and metrology systems utilized in the global semiconductor manufacturing process. The company’s product portfolio, including the Eagle and MicroProf platforms, provides 2D and 3D surface measurement and defect detection for advanced packaging, MEMS, and wafer-level packaging sectors. Headquartered in Israel, Camtek serves a diverse client base of integrated device manufacturers (IDMs) and outsourced semiconductor assembly and test (OSAT) providers across Asia, Europe, and North America.
The business model relies on the increasing complexity of semiconductor architecture, specifically the transition toward heterogeneous integration and 3D stacking which requires higher precision in quality control. As chips become smaller and more densely packed, the demand for metrology equipment grows because manual inspection is no longer viable for modern node sizes. The sector is characterized by high barriers to entry due to the significant research and development costs required to maintain optical accuracy at the micron level.
Investors may find additional insights on long-term performance trends by reviewing the data available on ValueRay. Camtek’s strategic focus on advanced packaging positions it within a critical bottleneck of the semiconductor supply chain as manufacturers seek to improve chip performance without relying solely on traditional transistor scaling.
- Advanced packaging demand for high performance computing drives heterogeneous integration revenue
- High bandwidth memory expansion fuels inspection and metrology tool adoption rates
- Geographic concentration in China exposes revenue to export controls and trade tensions
- Rapid semiconductor fabrication equipment cycles impact capital expenditure and order backlogs
- Geopolitical stability in Israel influences operational continuity and global supply chain logistics
| Net Income: 48.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -11.28 > 1.0 |
| NWC/Revenue: 165.3% < 20% (prev 121.2%; Δ 44.18% < -1%) |
| CFO/TA 0.11 > 3% & CFO 141.9m > Net Income 48.1m |
| Net Debt (-171.5m) to EBITDA (134.5m): -1.27 < 3 |
| Current Ratio: 8.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (51.5m) vs 12m ago 4.43% < -2% |
| Gross Margin: 50.23% > 18% (prev 0.50%; Δ 4.97k% > 0.5%) |
| Asset Turnover: 44.72% > 50% (prev 48.27%; Δ -3.55% > 0%) |
| Interest Coverage Ratio: 74.14 > 6 (EBITDA TTM 134.5m / Interest Expense TTM 1.66m) |
| A: 0.64 (Total Current Assets 937.5m - Total Current Liabilities 112.3m) / Total Assets 1.30b |
| B: 0.32 (Retained Earnings 418.2m / Total Assets 1.30b) |
| C: 0.11 (EBIT TTM 122.8m / Avg Total Assets 1.12b) |
| D: 0.68 (Book Value of Equity 416.7m / Total Liabilities 615.5m) |
| Altman-Z'' = 6.67 = AAA |
| DSRI: 1.19 (Receivables 131.7m/100.4m, Revenue 499.1m/450.9m) |
| GMI: 1.00 (GM 50.23% / 50.08%) |
| AQI: 1.03 (AQ_t 0.23 / AQ_t-1 0.22) |
| SGI: 1.11 (Revenue 499.1m / 450.9m) |
| TATA: -0.07 (NI 48.1m - CFO 141.9m) / TA 1.30b) |
| Beneish M = -2.85 (Cap -4..+1) = A |
As of May 25, 2026, the stock is trading at USD 167.37 with a total of 472,122 shares traded.
Over the past week, the price has changed by -0.58%,
over one month by -17.55%,
over three months by +2.19% and
over the past year by +153.51%.
Camtek has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CAMT.
- StrongBuy: 5
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 187.3 | 11.9% |
P/E Trailing = 155.9897
P/E Forward = 48.5437
P/S = 14.1291
P/B = 11.5038
P/EG = 3.468
Revenue TTM = 499.1m USD
EBIT TTM = 122.8m USD
EBITDA TTM = 134.5m USD
Long Term Debt = 487.8m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 498.8m USD (from shortLongTermDebtTotal, last quarter) + Leases 11.0m
Net Debt = -171.5m USD (calculated: Debt 498.8m - CCE 670.3m)
Enterprise Value = 6.88b USD (7.05b + Debt 498.8m - CCE 670.3m)
Interest Coverage Ratio = 74.14 (Ebit TTM 122.8m / Interest Expense TTM 1.66m)
EV/FCF = 130.8x (Enterprise Value 6.88b / FCF TTM 52.6m)
FCF Yield = 0.76% (FCF TTM 52.6m / Enterprise Value 6.88b)
FCF Margin = 10.54% (FCF TTM 52.6m / Revenue TTM 499.1m)
Net Margin = 9.63% (Net Income TTM 48.1m / Revenue TTM 499.1m)
Gross Margin = 50.23% ((Revenue TTM 499.1m - Cost of Revenue TTM 248.4m) / Revenue TTM)
Gross Margin QoQ = 50.08% (prev 50.03%)
Tobins Q-Ratio = 5.30 (Enterprise Value 6.88b / Total Assets 1.30b)
Interest Expense / Debt = 0.33% (Interest Expense 1.66m / Debt 498.8m)
Taxrate = 10.65% (3.77m / 35.4m)
NOPAT = 109.7m (EBIT 122.8m * (1 - 10.65%))
Current Ratio = 6.40 (Total Current Assets 937.5m / Total Current Liabilities 146.6m)
Debt / Equity = 0.73 (Debt 498.8m / totalStockholderEquity, last quarter 682.5m)
Debt / EBITDA = -1.27 (Net Debt -171.5m / EBITDA 134.5m)
Debt / FCF = -3.26 (Net Debt -171.5m / FCF TTM 52.6m)
Total Stockholder Equity = 626.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.31% (Net Income 48.1m / Total Assets 1.30b)
RoE = 7.68% (Net Income TTM 48.1m / Total Stockholder Equity 626.0m)
RoCE = 11.02% (EBIT 122.8m / Capital Employed (Equity 626.0m + L.T.Debt 487.8m))
RoIC = 9.25% (NOPAT 109.7m / Invested Capital 1.19b)
WACC = 12.49% (E(7.05b)/V(7.55b) * Re(13.35%) + D(498.8m)/V(7.55b) * Rd(0.33%) * (1-Tc(0.11)))
Discount Rate = 13.35% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 46.67 | Cagr: 2.07%
[DCF] Terminal Value 59.35% ; FCFF base≈88.9m ; Y1≈77.9m ; Y5≈63.0m
[DCF] Fair Price = 16.65 (EV 604.5m - Net Debt -171.5m = Equity 776.0m / Shares 46.6m; r=12.49% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 97.58 | EPS CAGR: 25.59% | SUE: 0.79 | # QB: 0
Revenue Correlation: 97.96 | Revenue CAGR: 23.02% | SUE: 1.04 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.76 | Chg30d=+1.36% | Revisions=+20% | Analysts=12
EPS next Quarter (2026-09-30): EPS=0.93 | Chg30d=+0.65% | Revisions=-14% | Analysts=12
EPS current Year (2026-12-31): EPS=3.50 | Chg30d=+1.77% | Revisions=+17% | GrowthEPS=+7.5% | GrowthRev=+15.2%
EPS next Year (2027-12-31): EPS=4.52 | Chg30d=+3.78% | Revisions=+33% | GrowthEPS=+29.2% | GrowthRev=+22.2%
[Analyst] Revisions Ratio: +33%